Quick Answer
International Stem Cell CORP reported Operating Income of -$267.0 thousand for fiscal year 2025.
International Stem Cell CORP Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$267.0K | -292.6% |
| 2024 | -$68.0K | +89.7% |
| 2023 | -$663.0K | -262.3% |
| 2022 | -$183.0K | +90.5% |
| 2021 | -$1.92M | +31.8% |
| 2020 | -$2.82M | +50.8% |
| 2019 | -$5.73M | -64.9% |
| 2018 | -$3.47M | +29.7% |
| 2017 | -$4.94M | -1.9% |
| 2016 | -$4.85M | -6.3% |
| 2015 | -$4.56M | +47.4% |
| 2014 | -$8.68M | -15.0% |
| 2013 | -$7.55M | +23.1% |
| 2012 | -$9.81M | +13.6% |
| 2011 | -$11.36M | -8.5% |
| 2010 | -$10.46M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $94.0K | +204.4% | -43.7% |
| June 30, 2025 | $167.0K | +12.1% | +177.7% |
| March 31, 2025 | -$215.0K | -20.8% | -138.9% |
| September 30, 2024 | -$90.0K | +7.2% | -160.4% |
| June 30, 2024 | $149.0K | +203.5% | +183.7% |
| March 31, 2024 | -$178.0K | -9000.0% | -83.5% |
| September 30, 2023 | -$97.0K | +67.7% | +32.6% |
| June 30, 2023 | -$144.0K | -564.5% | -7300.0% |
- International Stem Cell CORP showed a decrease of -292.6% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, International Stem Cell CORP’s operating income has grown by 97.4% (from -$10.46 million to -$267.0 thousand).
- The most recent figure is from International Stem Cell CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: